Associated Papers
Targeting the TRIB3-MYC axis in cancer: mechanistic insights and therapeutic disruption strategies.
Kamel EM et al.
Investigational New Drugs, 2025
UBE3B promotes breast cancer progression by antagonizing HIF-2α degradation.
Wang Y et al.
Oncogene, 2023
UBE3B Is a Calmodulin-regulated, Mitochondrion-associated E3 Ubiquitin Ligase.
Braganza A et al.
The Journal of Biological Chemistry, 2017
Select a paper to view details